Qiagen NV (QGEN)

50.59 +0.67  +1.34% NYSE Sep 18, 20:00 USD
View Full Chart
Price Chart
View All Events

Events

Date Type Description
10/30/2020 Earnings Qiagen NV Third Quarter Earnings for 2020 Release
10/30/2020 09:00 EDT Misc Qiagen NV Third Quarter Earnings Conference Call for 2020
08/04/2020 Earnings Qiagen NV Second Quarter Earnings Results for 2020
06/30/2020 09:00 EDT Misc Qiagen NV Annual General Meeting for 2019
05/06/2020 16:05 EDT Earnings Qiagen NV First Quarter Earnings Results for 2020
03/02/2020 Misc Qiagen NV Annual Report for 2019
02/05/2020 09:00 EST Misc Qiagen NV Fourth Quarter Earnings Conference Call for 2019
02/04/2020 Earnings Qiagen NV Fourth Quarter Earnings Results for 2019
10/31/2019 09:00 EDT Misc Qiagen NV Third Quarter Earnings Conference Call for 2019
10/30/2019 16:05 EDT Earnings Qiagen NV Third Quarter Earnings Results for 2019
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.qiagen.com
  • Investor Relations URL: https://www.qiagen.com/us/about-us/investors/
  • HQ State/Province: N/A
  • Sector: Healthcare
  • Industry: Diagnostics & Research
  • Equity Style: Mid Cap/Blend
  • Next Earnings Release: Oct. 30, 2020
  • Last Earnings Release: Aug. 04, 2020
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: N/A
  • Description: Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences (52% of 2019 sales) and molecular diagnostics (48% of sales). Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (47%), followed by EMEA (32%) and Asia-Pacific (21%).

Top Fund Holders

Symbol Name Weighting
PBE Invesco Dynamic Biotech & Genome ETF 5.04%
BCLPX BlackRock Event Driven Equity Inv C 4.76%
GNOM Global X Genomics & Biotechnology ETF 3.88%
FBT First Trust NYSE Arca Biotech ETF 3.88%
BBH VanEck Vectors Biotech ETF 3.33%
NWT475 NEI International Equity RS O 2.25%
DRIEQ Desjardins SocieTerra Intl Eq N 2.15%
BAHAX Brown Advisory WMC Strat Eurp Eq Adv 2.02%
VHCOX Vanguard Capital Opportunity Inv 1.74%
GF New Germany Fund 1.71%
ZLI.TO BMO Low Volatility International Eq ETF 1.70%
POAGX PRIMECAP Odyssey Aggressive Growth 1.50%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.